Steve Yemm MP: written questions

Steve Yemm MP: full overview

4 Jul 2025–3 Jul 2026

How these years work

Our reporting years run from 4 July to 3 July, starting with the 2024 general election. They are not official parliamentary sessions. Office costs keep IPSA’s April–March financial years. Records may cover only part of a year; a missing record does not mean no work was done.

Compare reporting years, sessions and IPSA financial years.

Written questions: dates and coverage

Source checked
21 Nov 2026
Last successful import
21 Nov 2026
Records dated through
20 Nov 2026
Selected period
Reporting year 2: 4 Jul 2025 to 3 Jul 2026
Completeness
Published snapshot: 25,747 records in the source window 23 Aug 2026 to 21 Nov 2026. The published snapshot covers its stated source window. Answers and corrections can appear later; no indexed answer does not prove that none exists.

How to read these datesOfficial source

Understand written questions, dates and answers.

Read what this MP said, asked and contributed in Parliament.

11 published records · newest first.

Written questions

  • Metabolic Dysfunction-associated SteatohepatitisDepartment of Health and Social CareTabled 13 May 2026AnsweredUIN 621More

    Question: To ask the Secretary of State for Health and Social Care, whether the transformation of liver services programme led by the NHS England Hepatobiliary and Pancreas Clinical Reference Group will include a specific workstream to help address the unmet clinic

    Answer: The transformation of liver services programme includes a number of workstreams including patient pathways relating to metabolic associated steatotic liver disease and metabolic dysfunction-associated steatohepatitis (MASH).NHS England is actively prepari...

    Answered 26 May 2026

    Original Parliament record
  • Liver Diseases: Health ServicesDepartment of Health and Social CareTabled 24 Apr 2026AnsweredUIN 129744More

    Question: To ask the Secretary of State for Health and Social Care, whether the liver transformation programme led by the Hepatobiliary and Pancreas Clinical Reference Group will include a specific work stream to help address the unmet clinical need in metabolic dy

    Answer: It has not proved possible to respond to the hon. Member in the time available before Prorogation.

    Answered 29 Apr 2026

    Original Parliament record
  • Chronic Obstructive Pulmonary Disease: Community Health ServicesDepartment of Health and Social CareTabled 24 Feb 2026AnsweredUIN 115665More

    Question: To ask the Secretary of State for Health and Social Care, what steps he is taking to ensure that patients with chronic obstructive pulmonary disease receive community-based care with specialist input; and what assessment he has made of the effectiveness o

    Answer: NHS England is investing £3.61 million of funding to expand an approach that allows more people with chronic obstructive pulmonary disease (COPD) at rising risk of admission to be proactively identified and supported during winter 2025/26. A nationally co...

    Answered 3 Mar 2026

    Original Parliament record
  • Liver Diseases: NottinghamshireDepartment of Health and Social CareTabled 16 Jan 2026AnsweredUIN 106402More

    Question: To ask the Secretary of State for Health and Social Care, what assessment he has made of the potential impact of trends in the number of patients with metabolic dysfunction–associated steatohepatitis on the NHS in (a) Nottinghamshire and (b) Mansfield con

    Answer: Data on hospital admission rates for metabolic dysfunction-associated steatotic liver disease (MASLD), of which metabolic dysfunction–associated steatohepatitis is a stage in some cases, is available at the Department’s Fingertips website, and can be used...

    Answered 2 Mar 2026

    Original Parliament record
  • Liver Diseases: Medical TreatmentsDepartment of Health and Social CareTabled 16 Jan 2026AnsweredUIN 106401More

    Question: To ask the Secretary of State for Health and Social Care, when he expects treatments for fatty liver disease to be approved for use on the NHS; what assessment he has made of the readiness of the NHS to make such treatments available; and what steps he is

    Answer: Newly licensed medicines are appraised by the National Institute for Health and Care Excellence (NICE), which is the independent body responsible for developing evidence-based guidance for the National Health Service on whether new medicines represent a c...

    Answered 6 Feb 2026

    Original Parliament record
  • Cancer: Young PeopleDepartment of Health and Social CareTabled 2 Jan 2026AnsweredUIN 102223More

    Question: To ask the Secretary of State for Health and Social Care, if he will meet with young people with cancer supported by Teenage Cancer Trust ahead of the publication of the National Cancer Plan.

    Answer: The Department is committed to ensuring the unique needs of young people with cancer are carefully considered as part of the National Cancer Plan, due for publication in the coming weeks. Since its launch on 4 February 2025, the Children and Young People ...

    Answered 8 Jan 2026

    Original Parliament record
  • Cancer: Young PeopleDepartment of Health and Social CareTabled 10 Oct 2025AnsweredUIN 80266More

    Question: To ask the Secretary of State for Health and Social Care, what policies his Department plans to include in the National Cancer Plan on increasing access to clinical trials for (a) teenagers and (b) young adults with cancer.

    Answer: The Department is committed to getting the National Health Service diagnosing cancer earlier and treating it faster, so that more people survive, and we will improve the experience of cancer patients across the system, including teenagers and young adults...

    Answered 20 Oct 2025

    Original Parliament record
  • Cancer: Young PeopleDepartment of Health and Social CareTabled 10 Oct 2025AnsweredUIN 80265More

    Question: To ask the Secretary of State for Health and Social Care, what policies his Department plans to include in the National Cancer Plan on the earlier diagnosis of (a) teenagers and (b) young adults with cancer.

    Answer: The Department is committed to getting the National Health Service diagnosing cancer earlier and treating it faster, so that more people survive, and we will improve the experience of cancer patients across the system, including teenagers and young adults...

    Answered 20 Oct 2025

    Original Parliament record
  • Cancer: Young PeopleDepartment of Health and Social CareTabled 10 Oct 2025AnsweredUIN 80264More

    Question: To ask the Secretary of State for Health and Social Care, if he will take steps to help improve data collection on (a) teenagers and (b) young adults with cancer in relation to (i) staging at diagnosis, (ii) routes to diagnosis, (iii) emergency presentati

    Answer: The Department is committed to getting the National Health Service diagnosing cancer earlier and treating it faster, so that more people survive, and we will improve the experience of cancer patients across the system, including teenagers and young adults...

    Answered 20 Oct 2025

    Original Parliament record
  • Cancer: Young PeopleDepartment of Health and Social CareTabled 10 Oct 2025AnsweredUIN 80263More

    Question: To ask the Secretary of State for Health and Social Care, what steps his Department plans to take to ensure that the National Cancer Plan for England provides age-appropriate information on the symptoms of cancer for young people.

    Answer: The Department is committed to getting the National Health Service diagnosing cancer earlier and treating it faster, so that more people survive, and we will improve the experience of cancer patients across the system, including teenagers and young adults...

    Answered 20 Oct 2025

    Original Parliament record
  • SclerodermaDepartment of Health and Social CareTabled 29 Aug 2025AnsweredUIN 72676More

    Question: To ask the Secretary of State for Health and Social Care, what steps he is taking to (a) improve early diagnosis, (b) increase funding for research and (c) improve access to specialist (i) support and (ii) treatment for patients with scleroderma.

    Answer: The Government is committed to improving the lives of those living with rare diseases, such as scleroderma. The UK Rare Diseases Framework sets out four priorities collaboratively developed with the rare disease community. These include helping patients g...

    Answered 11 Sep 2025

    Original Parliament record
Explore activity by topic or department

Written questions by answering department

4 Jul 2025–3 Jul 2026. One record per UIN and tabled date; the named department is not a measure of answer quality.

View as listDepartment for Business and Trade: 1Department for Business and Trade1Department for Culture, Media and Sport: 2Department for Culture, Media a…2Department for Education: 1Department for Education1Department for Energy Security and Net Zero: 2Department for Energy Security …2Department for Environment, Food and Rural Affairs: 1Department for Environment, Foo…1Department for Transport: 3Department for Transport3Department of Health and Social Care: 11Department of Health and Social…11Foreign, Commonwealth and Development Office: 1Foreign, Commonwealth and Devel…1Home Office: 1Home Office1Ministry of Housing, Communities and Local Government: 1Ministry of Housing, Communitie…1Ministry of Justice: 1Ministry of Justice1Treasury: 1Treasury1
What this shows and doesn't show
4 Jul 2025–3 Jul 2026. One record per UIN and tabled date; the named department is not a measure of answer quality. Published records do not measure effort or effectiveness. Methodology.
Department or topicPublished records
Department for Business and Trade1
Department for Culture, Media and Sport2
Department for Education1
Department for Energy Security and Net Zero2
Department for Environment, Food and Rural Affairs1
Department for Transport3
Department of Health and Social Care11
Foreign, Commonwealth and Development Office1
Home Office1
Ministry of Housing, Communities and Local Government1
Ministry of Justice1
Treasury1

Published records only — not a full account of an MP’s work. How we work →